Home R&D Page 14

R&D

Antimicrobial resistance. An underestimated hazard

Daclatasvir to treat chronic hepatitis C

Ataluren for a subgroup of Duchenne patients

Umeclidinium bromide in pulmonary disease

G1T28-1 in oncology treatments

New data on asfotase alfa in pediatric patients

Clinuvel’s phase II vitiligo study commences in Singapore

Delamanid, a novel drug for multidrug-resistant tuberculosis

Propandiol in infantile haemangioma

New vaccine candidates against malaria enter clinical development

1...13141516Page 14 of 16
© © 2025 Tecniche Nuove Spa - All rights reserved. Registered office: Via Eritrea 21 - 20157 Milan. Share capital: 5,000,000 Euro fully paid up. Tax code, VAT number and registration with the Milan Register of Companies: 00753480151